We are live on ! Find out more
DWM

Doyle Wealth Management Portfolio holdings

AUM $1.16B
1-Year Est. Return 9.32%
This Fund
S&P 500
This Quarter Est. Return
-10.08%
1 Year Est. Return
-9.32%
3 Year Est. Return
+32.31%
5 Year Est. Return
+58.61%
10 Year Est. Return
AUM
$592M
AUM Growth
-$51.2M
Cap. Flow
+$28.5M
Cap. Flow %
4.81%
Top 10 Hldgs %
32.11%
Holding
878
New
685
Increased
81
Reduced
89
Closed
3

Top Buys

Rank Stock Value
1
TJX icon
TJX Companies
TJX
+$10.7M
2
BAX icon
Baxter International
BAX
+$9.12M
3
GS icon
Goldman Sachs
GS
+$8.34M
4
KHC icon
Kraft Heinz
KHC
+$6.47M
5
PAYX icon
Paychex
PAYX
+$6.1M

Top Sells

Rank Stock Value
1
BMY icon
Bristol-Myers Squibb
BMY
+$15M
2
NOV icon
NOV
NOV
+$9.78M
3
SLB icon
SLB Ltd
SLB
+$8.68M
4
EIX icon
Edison International
EIX
+$8.56M
5
IBM icon
IBM
IBM
+$7.64M

Sector Composition

Rank Sector Weight
1 Financials 16.71%
2 Healthcare 14.86%
3 Technology 13.49%
4 Miscellaneous 13.24%
5 Consumer Staples 11.45%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake
Capital Flow
JTA
876
DELISTED
Nuveen Tax-Advantaged Total Return Strategy Fund
JTA
$0 ﹤0.01%
+10
New +$117
VXX
877
DELISTED
iPath S&P 500 VIX Short-Term Futures ETN due 1/30/2019
VXX
$0 ﹤0.01%
+1
New +$37

Similar funds

Doyle Wealth Management's Q4 2018 Portfolio in Review

As of Q4 2018, Doyle Wealth Management held 878 positions worth $592M, down 8% from $644M the previous quarter. Its ten largest holdings account for 32% of the portfolio.

Doyle Wealth Management deployed $28.5M of net new capital in Q4 2018, opening 685 new positions and adding to 81 existing holdings. Its largest new stake was TJX Companies: 211,505 shares worth $9.46M.

By sector, the portfolio is most concentrated in Financials at 17% of assets, up from 16% a quarter earlier, followed by Healthcare and Technology.

On the sell side, the largest reduction was Bristol-Myers Squibb, an estimated $15M trimmed.

  • Doyle Wealth Management's largest Q4 2018 buy was TJX Companies: 211,505 shares worth $9.46M.
  • Doyle Wealth Management added most to Baxter International in Q4 2018, an estimated $9.12M increase.
  • Doyle Wealth Management's biggest Q4 2018 reduction was Bristol-Myers Squibb, cutting an estimated $15M.
  • Doyle Wealth Management fully exited Aetna Inc in Q4 2018, selling an estimated $412K.
  • Doyle Wealth Management's ten largest holdings make up 32% of its $592M portfolio in Q4 2018.
  • Doyle Wealth Management opened 685 new positions and closed 3 in Q4 2018.
  • Doyle Wealth Management's portfolio value fell 8% quarter-over-quarter to $592M.

Based on Doyle Wealth Management's 13F filing for Q4 2018, filed 8 Feb 2019.